Bayesian Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Bayesian Capital Management's CL Position: Q3 2026 in Review
Bayesian Capital Management opened a new position in Colgate-Palmolive (CL) in Q3 2026: 5,200 shares worth $444K. The stake represents 0.35% of the portfolio and ranks #79 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in CL as recently as Q2 2025.
Bayesian Capital Management first reported a position in CL in Q3 2016 and has held it in 14 quarters since. The position peaked at $3.64M in Q2 2023. 1,966 funds tracked by Wall St. Rank hold CL as of Q3 2026.
- Bayesian Capital Management held 5,200 shares of Colgate-Palmolive worth $444K as of Q3 2026.
- Colgate-Palmolive was a new Bayesian Capital Management position in Q3 2026.
- Colgate-Palmolive made up 0.35% of Bayesian Capital Management's portfolio in Q3 2026, its #79 holding.
- Bayesian Capital Management first reported a position in Colgate-Palmolive in Q3 2016 and has held it in 14 quarters since.
- Bayesian Capital Management's Colgate-Palmolive position peaked at $3.64M in Q2 2023.
- 1,966 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.
Based on Bayesian Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.